Targeting Oxidative Stress with Antioxidant Duotherapy after Experimental Traumatic Brain Injury

Autor: Jenni, Kyyriäinen, Natallie, Kajevu, Ivette, Bañuelos, Leonardo, Lara, Anssi, Lipponen, Silvia, Balosso, Elina, Hämäläinen, Shalini, Das Gupta, Noora, Puhakka, Teemu, Natunen, Teresa, Ravizza, Annamaria, Vezzani, Mikko, Hiltunen, Asla, Pitkänen
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: International Journal of Molecular Sciences, Vol 22, Iss 10555, p 10555 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 19
ISSN: 1661-6596
1422-0067
Popis: We assessed the effect of antioxidant therapy using the Food and Drug Administration-approved respiratory drug N-acetylcysteine (NAC) or sulforaphane (SFN) as monotherapies or duotherapy in vitro in neuron-BV2 microglial co-cultures and validated the results in a lateral fluid-percussion model of TBI in rats. As in vitro measures, we assessed neuronal viability by microtubule-associated-protein 2 immunostaining, neuroinflammation by monitoring tumor necrosis factor (TNF) levels, and neurotoxicity by measuring nitrite levels. In vitro, duotherapy with NAC and SFN reduced nitrite levels to 40% (p <
0.001) and neuroinflammation to –29% (p <
0.001) compared with untreated culture. The treatment also improved neuronal viability up to 72% of that in a positive control (p <
0.001). The effect of NAC was negligible, however, compared with SFN. In vivo, antioxidant duotherapy slightly improved performance in the beam walking test. Interestingly, duotherapy treatment decreased the plasma interleukin-6 and TNF levels in sham-operated controls (p <
0.05). After TBI, no treatment effect on HMGB1 or plasma cytokine levels was detected. Also, no treatment effects on the composite neuroscore or cortical lesion area were detected. The robust favorable effect of duotherapy on neuroprotection, neuroinflammation, and oxidative stress in neuron-BV2 microglial co-cultures translated to modest favorable in vivo effects in a severe TBI model.
Databáze: OpenAIRE